Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Chrostek

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Brain Research|August 6, 2019
Efficacy of stem cell-based therapies for strokeMatthew R Chrostek, Emily G Fellows, Andrew T Crane, et al.
Brain Sciences|October 30, 2019
Efficacy of Cell-Based Therapies for Traumatic Brain InjuriesMatthew R Chrostek, Emily G Fellows, Winston L Guo, et al.
JCO Precision Oncology|March 5, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language ModelsS Carson Callahan, Matthew R Chrostek, Nicholas Rydzewski, et al.
Science Advances|December 1, 2021
ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survivalMichael A Harris, Huihui Kuang, Zachary Schneiderman, et al.
NPJ Precision Oncology|October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapyHamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Investigational New Drugs|March 3, 2026
Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534Matthew R Chrostek, James Robinson, Rajesh Krishnan, et al.
Plos One|October 1, 2020
Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cellsAndrew T Crane, Matthew R Chrostek, Venkatramana D Krishna, et al.
Communications Biology|March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifierNicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
JCI Insight|September 24, 2024
Clinical cell-surface targets in metastatic and primary solid cancersMarina N Sharifi, Yue Shi, Matthew R Chrostek, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Brain Research|August 6, 2019
Efficacy of stem cell-based therapies for strokeMatthew R Chrostek, Emily G Fellows, Andrew T Crane, et al.
Brain Sciences|October 30, 2019
Efficacy of Cell-Based Therapies for Traumatic Brain InjuriesMatthew R Chrostek, Emily G Fellows, Winston L Guo, et al.
JCO Precision Oncology|March 5, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language ModelsS Carson Callahan, Matthew R Chrostek, Nicholas Rydzewski, et al.
Science Advances|December 1, 2021
ssDNA nanotubes for selective targeting of glioblastoma and delivery of doxorubicin for enhanced survivalMichael A Harris, Huihui Kuang, Zachary Schneiderman, et al.
NPJ Precision Oncology|October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapyHamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Investigational New Drugs|March 3, 2026
Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534Matthew R Chrostek, James Robinson, Rajesh Krishnan, et al.
Plos One|October 1, 2020
Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cellsAndrew T Crane, Matthew R Chrostek, Venkatramana D Krishna, et al.
Communications Biology|March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifierNicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
JCI Insight|September 24, 2024
Clinical cell-surface targets in metastatic and primary solid cancersMarina N Sharifi, Yue Shi, Matthew R Chrostek, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Pageof 2